Zhongnan Medical Journal Press

Home Results

A total of 2036 result was found. Results that relate to M

Effect of Shengjiyuhong ointment on coagulation system, EPCs differentiation and Rho kinase activity in rats with thromboangiitis obliterans by inhibiting autophagy

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):919-927.
6383 times 1570 times

CHEN Kui MA Liangliang XU Yindong SHI Li

Shengjiyuhong ointment Autophagy Thromboangiitis obliterans Coagulation system EPCs differentiation Rho kinase activity
Details
HPLC fingerprint and three main components determination of Modified Zengye Decoction

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):928-936.
6619 times 1838 times

LIU Shiqi WU Chuang ZHU Zhimin XU Feng CHANG Yaowen ZHANG Haiyan GOU Xiaojun

Modified Zengye Decoction Ferulic acid Aurantiamarin Harpagoside High performance liquid chromatography Fingerprint Content determination Quality control
Details
Quality analysis of Xiao’er Magan granules based on chemometrics combined with quantitative analysis of different components

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):937-950.
8529 times 1754 times

FEI Yiqin LYU Pan YANG Ping ZHAN Fangling XU Ling

Xiao’er Magan granules Chemometrics Fingerprints Difference analysis of component content Ultra-performance liquid chromatography/quadrupole time-of-flight-tandem mass spectrometry Quality analysis
Details
The improvement of intestinal immune barrier function in immunoglobulin A nephropathy rats by Atractylolactone-III nanoparticles

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):951-960.
6241 times 1607 times

LIN Shengfen CAI Xiaoqiao LIN Yongqiang WANG Chaochao

Atractonolide III IgA nephropathy Intestinal immunity Intestinal permeability
Details
Inhibition of lupinol on the malignant progression of lung cancer A549 cells through regulating Notch signaling pathway

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):961-968.
8010 times 1499 times

YIN Bingyi LIN Hongsheng ZHANG Chuchu

Lupeol Notch signaling pathway Lung cancer cell Proliferation Apoptosis Migration Invasion
Details
Study on the influence of different stabilizers on the stability of quercetin nanocrystals

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):969-974.
6765 times 1784 times

DU Yukun WANG Lifu KANG Xin PAN Zhenhua DANG Yunjie

Quercetin Nanocrystals Stabilizers Povidone K30 Polosham F188 Sodium dodecyl sulfate Stability
Details
Effect of granulocyte colony-stimulating factor combined with tadalafil on endometrial receptivity and pregnancy outcomes in patients with thin endometrium

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):984-991.
6311 times 1490 times

SHI Hongzhen SUN Lijuan WANG Lin WANG Qian ZHANG Shuang LIN Lin

Thin endometrium Granulocyte colony stimulating factor Tadalafil Endometrial receptivity Pregnancy outcome
Details
Risk assessment and prediction model for capecitabine-induced chemotherapy-related adverse reactions in colorectal cancer patients

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):992-998.
6523 times 1580 times

CHEN Shaobo WU Xutao QIU Wenhui HU Tingting

Colorectal cancer Capecitabine Chemotherapy-induced adverse efects Risk prediction model
Details
The effect of seritaline and multidisciplinary collaborative management model on adolescents with first-episode major depression disorder

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):999-1006.
8404 times 1735 times

RU Guifang LI Yuanlin GAO Min

Major depressive disorder Sertraline Multidisciplinary collaborative management model Emotion Inflammatory factor
Details
Study on immune biomarker of gout and screening of related target Chinese medicine based on the xCell algorithm

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1007-1018.
8566 times 1698 times

LI Lingqin ZHOU Ruijiao ZHANG Yanni YUAN Xinzhu

Gout Chinese medicine Bioinformatics Immune markers Arthritis Metabolic syndrome Monosodium urate Gene microarray
Details
CiteSpace bibliometric analysis of safety and risk studies of antibody drugs in China

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1019-1027.
6368 times 1631 times

PENG Yue LIU Lingling CAI Yuanxuan ZHAO Yuhang SHANGGUAN Xiaofang LI Kangling CHEN Zherui LI Ke HUANG Rui LU Yuanyuan

Antibody drugs CiteSpace Safety Risk Adverse reactions Bibliometrics Drug safety Risk management
Details
Prevention effect of ceftriaxone sodium combined with bundle management on early ventilator-associated pneumonia

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1028-1033.
6062 times 1420 times

HE Yin GAI Tiantian HAN Zunhai

Ceftriaxone Bundle management Early ventilator-associated pneumonia Prevention Mechanical ventilation
Details
The prediction value of depressive symptom dimensions in the efficacy of high-frequency repetitive transcranial magnetic stimulation combined with flupentixol and melitracen tablets for post-stroke depression

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1034-1040.
7447 times 1400 times

JIANG Yanping ZHANG Ruilian XUE Chengchuan LIU Xianxiu

Depressive symptom dimension Repeated transcranial magnetic stimulation Flupentixol and melitracen tablets Efficacy Prediction
Details
Efficacy of interferon α-2b combined with chlorquinaldol-promestriene on cervical intraepithelial neoplasia patients after loop electrosurgical excisional procedure

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1041-1047.
7690 times 1635 times

SU Yanyan YANG Hu

Cervical intraepithelial neoplasia Interferon α-2b Chlorquinaldol-promestriene Loop electrosurgical excisional procedure
Details
Application value of amlodipine/atorvastatin combined with evidence-based emotional nursing mode in elderly patients with hypertension complicated by coronary heart disease

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1048-1054.
8622 times 1506 times

WU Xiangna JIN Liya LIANG Pingping LIN Duoduo ZHENG Wenxian

Amlodipine/atorvastatin Evidence-based emotional nursing mode Hypertension Coronary heart disease Elderly Compliance
Details